RIGEL PHARMACEUTICALS INC (RIGL) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$294.3M

Net Income/Loss (FY2025)

$367.0M

Total Assets (FY2025)

$513.6M

Total Equity (FY2025)

$391.5M

Cash Flows from Operating Activities (FY2025)

$75.7M

Source: RIGEL PHARMACEUTICALS INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.